Xenon Pharmaceuticals
XENE
$43.75
Share price
1.74%
Change (1 day)
7.28%
Change (1 year)
Categories
Xenon Pharmaceuticals (XENE) - P/B ratio
P/B ratio as of May 2024 : 3.50
According to Xenon Pharmaceuticals's latest financial reports the company has a price-to-book ratio of 3.50.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Xenon Pharmaceuticals - P/B ratio (from 2014 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 3.74 | 9.32% |
| 2022-12-31 | 3.42 | 16.65% |
| 2021-12-31 | 2.93 | -6.76% |
| 2020-12-31 | 3.14 | -21.65% |
| 2019-12-31 | 4.01 | 154.97% |
| 2018-12-31 | 1.57 | 11.17% |
| 2017-12-31 | 1.41 | -34.37% |
| 2016-12-31 | 2.16 | 13.78% |
| 2015-12-31 | 1.89 | -50.76% |
| 2014-12-31 | 3.85 | |
| 2013-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Coherus BioSciences
CHRS | -1.27 | -136.41% | 🇺🇸 USA |
 Atara Biotherapeutics ATRA | -0.7822 | -122.37% | 🇺🇸 USA |